Invokana® (Canagliflozin Tablets) – 100 mg | 300 mg

Invokana is an SGLT-2 inhibitor tablet that lowers blood sugar and supports metabolic health in Type 2 diabetes.

Invokana® (Canagliflozin Tablets) is an oral antidiabetic medicine belonging to the SGLT-2 inhibitor class, indicated for the management of type 2 diabetes mellitus. It works by reducing glucose reabsorption in the kidneys, helping excess glucose to be eliminated through urine and thereby improving glycemic control.

Invokana is widely prescribed due to its additional benefits in cardiovascular and renal risk reduction in eligible patients. It may be used as monotherapy or in combination with other antidiabetic agents such as metformin, DPP-4 inhibitors, or insulin, as advised by healthcare professionals.

Available strengths include 100 mg and 300 mg tablets, offering flexible dosing options based on patient response and clinical needs.

Medicina Overseas supplies Invokana® tablets for international export, serving pharmacies, hospitals, wholesalers, and importers with reliable sourcing, compliant packaging, and bulk supply options.

⚠️ Prescription medicine. To be used under medical supervision only.

✅ KEY USES (OPTIONAL – CONVERSION BOOST)

• Management of type 2 diabetes

• Helps lower blood glucose levels

• Supports cardiovascular and renal outcomes in eligible patients

• Once-daily oral therapy